Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,246
  • Shares Outstanding, K 13,437
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,700 K
  • 60-Month Beta 1.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.37
Trade HOTH with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6000 +6.25%
on 11/02/20
1.9000 -10.53%
on 11/06/20
-0.1800 (-9.57%)
since 10/23/20
3-Month
1.6000 +6.25%
on 11/02/20
2.7500 -38.18%
on 08/31/20
-0.7700 (-31.17%)
since 08/21/20
52-Week
1.6000 +6.25%
on 11/02/20
7.2500 -76.55%
on 12/30/19
-2.9400 (-63.36%)
since 11/22/19

Most Recent Stories

More News
Voltron Therapeutics, Inc. to Participate in the 2020 Fall Defense TechConnect Virtual Innovation Summit

Voltron Therapeutics, Inc. today announced that it will participate in the 2020 Fall TechConnect Virtual Innovation Conferences' Virtual Defense TechConnect Innovation Summit. The conference will be held...

HOTH : 1.7000 (-1.73%)
Hoth Therapeutics Announces Positive, Statistically Significant Proof-of-Concept Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a  today announced positive, statistically significant proof-of-concept preclinical data on its therapeutic HT-005 for the treatment of Cutaneous...

HOTH : 1.7000 (-1.73%)
Hoth Therapeutics Provides Update for Novel COVID-19 Therapeutic, On-the-Go SARS-CoV-2 Testing Device, and Vaccine

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a , today announced key upcoming milestones towards the commercial development of the novel COVID-19 products currently being developed. Hoth...

HOTH : 1.7000 (-1.73%)
Hoth Therapeutics Announces USPTO Grant of Patent for Targeted 13-Cis-RAMBA Retinamides for Development as a Novel Cancer Therapeutic

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a , today announced that through its commercial licensing agreement with the (UMB) the U.S. Patent and Trademark Office (USPTO) has granted...

HOTH : 1.7000 (-1.73%)
Hoth Therapeutics Announces its HT-003 Shows Positive Initial Data Inhibiting Toll-like Receptor 2 (TLR2)

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a  today announced completing testing to examine the ability of HT-003 to block acne pathogenic gene expression in human keratinocytes, the major...

HOTH : 1.7000 (-1.73%)
Sidoti Virtual Investor Conference

Sidoti & Company, LLC has released the presentation schedule, with weblink click-throughs, for Wednesday, September 23, 2020, the first day of its two-day Fall 2020 Virtual Investor Conference. The presentation...

ATEN : 8.16 (+3.16%)
ABM : 39.18 (+2.43%)
ACA : 54.79 (+3.49%)
ACU : 32.35 (-1.10%)
ALEX : 16.16 (+4.12%)
WTERD : 0.6500 (-7.14%)
AUDC : 28.25 (+5.33%)
AVA : 38.40 (+2.37%)
AZZ : 42.81 (+3.53%)
BCPC : 103.25 (-0.54%)
BBSI : 68.19 (+0.07%)
BHE : 24.71 (+3.61%)
BKH : 62.48 (+0.94%)
BRC : 45.47 (-1.52%)
CSV : 28.90 (+0.03%)
CSWI : 110.33 (+1.69%)
CTS : 31.17 (+1.40%)
DYAI : 5.98 (-7.57%)
BOOM : 43.31 (+4.79%)
NPO : 70.74 (+3.18%)
XONE : 11.02 (+1.66%)
EZPW : 5.43 (+0.93%)
FAT : 6.00 (+5.26%)
AGM : 68.20 (+0.80%)
FSS : 32.12 (+1.20%)
FORR : 42.32 (+1.20%)
GRC : 34.10 (+0.95%)
HVT : 28.81 (+3.41%)
HAYN : 22.64 (+0.09%)
HRTG : 10.67 (+0.47%)
MLHR : 37.52 (+2.15%)
HSKA : 129.18 (+1.76%)
HNI : 37.42 (-1.34%)
HOFT : 30.11 (+1.55%)
HOTH : 1.7000 (-1.73%)
HURN : 43.80 (+2.50%)
ICFI : 74.35 (+1.35%)
IMMR : 8.10 (-0.49%)
INFU : 15.26 (+2.07%)
IIIN : 25.28 (-0.12%)
INS : 38.71 (+1.12%)
KAI : 131.61 (+0.19%)
LZB : 38.78 (-1.37%)
LMAT : 38.88 (+2.99%)
LPTH : 2.92 (+3.18%)
LINC : 6.53 (+5.49%)
MTX : 61.00 (+2.85%)
MG : 5.02 (+2.03%)
MOD : 11.50 (+6.09%)
NP : 46.44 (+3.82%)
ODP : 29.10 (+1.29%)
CNXN : 45.08 (+0.22%)
PBI : 5.64 (-1.23%)
POWL : 27.28 (+1.87%)
PRIM : 24.87 (+4.54%)
QADA : 49.12 (-0.37%)
KWR : 252.80 (-0.51%)
RDNT : 18.57 (+1.64%)
SWM : 35.31 (+0.57%)
SREV : 1.3900 (unch)
STRA : 90.15 (+1.16%)
SYX : 31.04 (+2.68%)
TTEC : 65.07 (+0.02%)
TTEK : 122.50 (+0.70%)
TWI : 5.22 (+4.61%)
TNXP : 0.5750 (-0.90%)
TRNS : 31.86 (+2.67%)
UFI : 15.44 (-0.45%)
UEIC : 51.87 (+1.73%)
UTI : 6.13 (+0.33%)
VVI : 30.42 (+4.07%)
VPG : 29.40 (+1.91%)
WGO : 53.13 (+5.75%)
YTRA : 1.6100 (+11.03%)
Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced  that it has entered into a Sponsored Research Agreement ("SRA") with the ("GW") relating to...

HOTH : 1.7000 (-1.73%)
Voltron Therapeutics, Inc. Executes Manufacturing Agreement with Global Pharmaceutical Contract Development and Manufacturing Organization

Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global pharmaceutical contract development and manufacturing organization. The...

HOTH : 1.7000 (-1.73%)
Voltron Therapeutics, Inc. Announces Completion of First Small Animal Safety and Immunogenicity Study Assessing the Effect of Novel COVID-19 Vaccine, HaloVax(TM)

Voltron Therapeutics, Inc. announced today the successful completion of its previously announced first small animal safety and immunogenicity study assessing the effect of novel Covid-19 vaccine HaloVax(TM)....

HOTH : 1.7000 (-1.73%)
Hoth Therapeutics' Chief Scientific Officer, Dr. Stefanie Johns, to Appear on One America News Network on Tuesday, September 1, 2020

, , 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced  Dr. , who has agreed to join Hoth and serve as its Chief Scientific Officer, is scheduled...

HOTH : 1.7000 (-1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is...

See More

Key Turning Points

2nd Resistance Point 1.7812
1st Resistance Point 1.7406
Last Price 1.7000
1st Support Level 1.6747
2nd Support Level 1.6494

See More

52-Week High 7.2500
Fibonacci 61.8% 5.0917
Fibonacci 50% 4.4250
Fibonacci 38.2% 3.7583
Last Price 1.7000
52-Week Low 1.6000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar